Demographic characteristics and “disease-related factors” play a role in the unmet supportive care needs of patients diagnosed with lung cancer, according to a recent study published in the Journal of Multidisciplinary Healthcare. The research was performed by a team of investigators from Taiwan, with the aim of evaluating the unmet supportive care needs of patients with lung cancer throughout cancer treatment and across different stages of the disease, including those already receiving treatment and those who were recently diagnosed. ...
Advertisement
Most patients with MPM experience pleural effusion, but questions remain about the condition's impact on patient outcomes.
The NCCN 2025 Annual Conference will be held from March 28-30 in Orlando, Florida.
Expanded treatment options for pleural mesothelioma are "urgently needed," due to the high morbidity of the disease.
Investigators of a phase 2 study uncovered a biomarker that may be associated with major pathologic response in this setting.
The Lung Cancer Screening Registry will evolve into the Early Lung Cancer Detection Registry.
The multicenter, single-arm trial is evaluating the novel antibody–drug conjugate, also known as SHR-A1811.
Mara B. Antonoff, MD, FACS, discusses the organization's mission, the resources it offers, and her hopes for the future.
Learn how researchers determined the best treatment strategy for smoking cessation among patients who currently smoke.
The majority of symptoms at baseline consisted of pain, dyspnea, and fatigue.
The study investigators concluded that ivonescimab “might represent another treatment option in the first-line setting."
Roundtable Discussions
Expert Interviews
Conference Coverage
Find key news in thoracic oncology from the 61st Annual Meeting of the Society of Thoracic Surgeons.
Find the latest news and updates on lung cancer from the ESMO Congress 2024.
Find the latest updates on lung cancer treatment and research from the IASLC 2024 World Conference on Lung Cancer.
Find the latest updates on lung cancer treatment and research from the 2024 ASCO Annual Meeting.
Our editors detail the latest data and innovations in the lung cancer space presented at ATS 2024.
Our editors provide coverage on the development of innovative cancer therapeutics, as presented at ESMO TAT 2024.
Our editors deliver in-depth coverage of NACLC 2023, a premier event offering the latest data on lung cancer advancements.
Our editors provide comprehensive coverage of ESMO Congress 2023, with a focus on lung cancer.
Our editors detail the latest data and innovations in the lung cancer space, as presented at WCLC 2023.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.